Eris Lifesciences, 540596, ERIS Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

19,867.08
32.07
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

21,914.88
0.50%
5.09

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

17.10
19.01
19.75

EBITDA CAGR (%)

10 Years
5 Years
3 Years

19.47
18.75
13.64

PAT CAGR (%)

10 Years
5 Years
3 Years

10.17
-0.19
-2.72

P:E (Median)

8 Years
5 Years
3 Years

27.83
30.68
44.91

P:BV (Average)

8 Years
5 Years
3 Years

5.89
5.61
6.02

EV:EBITDA (Average)

8 Years
5 Years
3 Years

20.36
20.47
21.65

Earnings Forecasts:

(Updated: 23-06-2026)

Description 2026 2027 2028 2029
Adj EPS 36.11 48.59 61.21 73.95
P/E Ratio 39.78 29.57 23.47 19.43
Revenue 3215.37 3628.49 4120.59 4645.35
EBITDA 1148.66 1322.23 1524.86 1731.77
Net Income 495.08 667.76 840.46 1015.05
ROA 8.49 10.23 11.8 14.55
P/B Ratio 5.78 4.46 3.85 3.35
ROE 16.78 15.91 17.3 17.78
FCFF -21.44 -627.45 -611.2 132.96
FCFF Yield -0.1 -2.87 -2.8 0.61
Net Debt 1961.58 1504.49 870.82 164.9
BVPS 248.51 322.45 373.36 429.13

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 277.31 404.77 -31.49% 315.29 399.73 -21.12% 650.50 436.56 49.01% 578.64 456.69 26.70%
Expenses 255.53 283.80 -9.96% 237.94 300.16 -20.73% 353.62 293.93 20.31% 362.32 333.31 8.70%
EBITDA 21.78 120.97 -82.00% 77.35 99.57 -22.32% 296.88 142.63 108.15% 216.32 123.38 75.33%
EBIDTM 7.85% 29.89% 24.53% 24.91% 45.64% 32.67% 37.38% 27.02%
Other Income 26.97 16.75 61.01% 25.07 7.79 221.82% 23.59 5.81 306.02% 22.68 5.16 339.53%
Interest 42.70 53.16 -19.68% 45.20 54.65 -17.29% 46.50 56.26 -17.35% 45.14 56.17 -19.64%
Depreciation 38.82 43.38 -10.51% 38.66 46.68 -17.18% 39.30 46.16 -14.86% 37.60 45.55 -17.45%
PBT -32.77 41.18 - 3.89 6.03 -35.49% 234.67 46.02 409.93% 156.26 26.82 482.62%
Tax -24.17 10.71 - 0.80 4.25 -81.18% 85.10 17.92 374.89% 56.27 9.78 475.36%
PAT -8.60 30.47 - 3.09 1.78 73.60% 149.57 28.10 432.28% 99.99 17.04 486.80%
PATM -3.10% 7.53% 0.98% 0.45% 22.99% 6.44% 17.28% 3.73%
EPS -0.62 2.20 - 0.22 0.13 69.23% 10.80 2.03 432.02% 7.22 1.23 486.99%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 756.56 705.30 7.27% 807.45 727.45 11.00% 792.41 741.17 6.91% 773.00 719.72 7.40%
Expenses 482.99 452.91 6.64% 525.84 477.14 10.21% 504.20 476.66 5.78% 496.29 469.73 5.65%
EBITDA 273.57 252.39 8.39% 281.61 250.31 12.50% 288.21 264.51 8.96% 276.71 249.99 10.69%
EBIDTM 36.16% 35.78% 34.88% 34.41% 36.37% 35.69% 35.80% 34.73%
Other Income 2.23 7.95 -71.95% 0.02 4.22 -99.53% 2.81 4.55 -38.24% 2.69 1.64 64.02%
Interest 45.62 54.28 -15.95% 48.82 57.17 -14.61% 49.55 59.47 -16.68% 48.68 60.37 -19.36%
Depreciation 69.57 77.25 -9.94% 70.34 81.00 -13.16% 69.08 80.38 -14.06% 70.51 75.74 -6.91%
PBT 160.61 128.81 24.69% 145.23 116.36 24.81% 172.39 129.21 33.42% 160.21 115.52 38.69%
Tax -119.69 26.52 - 36.52 29.30 24.64% 38.20 32.80 16.46% 36.00 25.97 38.62%
PAT 280.30 102.29 174.02% 108.71 87.06 24.87% 134.19 96.41 39.19% 124.21 89.55 38.70%
PATM 37.05% 14.50% 13.46% 11.97% 16.93% 13.01% 16.07% 12.44%
EPS 20.33 6.89 195.07% 7.32 6.15 19.02% 8.82 6.73 31.05% 8.66 6.12 41.50%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,821.74 1,697.75 1,486.71 1,330.72 1,215.73 1,108.83 1,020.23 896.54 760.60 712.90 605.48 Net Sales Growth 7.30% 14.20% 11.72% 9.46% 9.64% 8.68% 13.80% 17.87% 6.69% 17.74% Cost Of Goods Sold 626.70 499.25 280.16 236.38 199.65 198.51 164.35 132.35 115.94 135.66 116.14 Gross Profit 1,195.04 1,198.50 1,206.55 1,094.34 1,016.08 910.32 855.88 764.19 644.67 577.24 489.33 GP Margin 65.60% 70.59% 81.16% 82.24% 83.58% 82.10% 83.89% 85.24% 84.76% 80.97% 80.82% Total Expenditure 1,209.41 1,211.20 1,032.89 825.61 731.67 691.36 665.28 562.77 444.67 441.70 435.01 Power & Fuel Cost - 4.10 4.46 4.41 4.01 3.89 4.54 3.34 3.04 2.93 2.74 % Of Sales - 0.24% 0.30% 0.33% 0.33% 0.35% 0.44% 0.37% 0.40% 0.41% 0.45% Employee Cost - 361.92 331.67 252.52 220.11 207.02 191.73 166.77 130.84 116.31 122.36 % Of Sales - 21.32% 22.31% 18.98% 18.11% 18.67% 18.79% 18.60% 17.20% 16.32% 20.21% Manufacturing Exp. - 15.17 19.99 14.18 38.89 11.87 14.63 8.09 4.97 4.47 6.40 % Of Sales - 0.89% 1.34% 1.07% 3.20% 1.07% 1.43% 0.90% 0.65% 0.63% 1.06% General & Admin Exp. - 155.47 211.47 154.78 135.40 110.76 125.31 122.99 92.81 106.48 102.91 % Of Sales - 9.16% 14.22% 11.63% 11.14% 9.99% 12.28% 13.72% 12.20% 14.94% 17.00% Selling & Distn. Exp. - 147.70 140.07 137.77 98.34 109.88 131.07 125.15 95.36 72.99 82.35 % Of Sales - 8.70% 9.42% 10.35% 8.09% 9.91% 12.85% 13.96% 12.54% 10.24% 13.60% Miscellaneous Exp. - 27.59 45.07 25.57 35.28 49.43 33.64 4.09 1.71 2.85 82.35 % Of Sales - 1.63% 3.03% 1.92% 2.90% 4.46% 3.30% 0.46% 0.22% 0.40% 0.35% EBITDA 612.33 486.55 453.82 505.11 484.06 417.47 354.95 333.77 315.93 271.20 170.47 EBITDA Margin 33.61% 28.66% 30.53% 37.96% 39.82% 37.65% 34.79% 37.23% 41.54% 38.04% 28.15% Other Income 98.31 35.51 34.83 17.26 28.99 10.00 15.49 32.50 28.22 25.08 3.28 Interest 179.54 220.24 57.42 20.81 3.05 0.94 1.97 22.90 10.48 0.85 0.28 Depreciation 154.38 181.77 102.39 64.66 51.45 37.64 44.88 31.59 21.79 21.44 19.55 PBT 362.05 120.05 328.84 436.91 458.54 388.89 323.59 311.78 311.89 273.99 153.93 Tax 118.00 42.66 29.12 38.90 41.35 38.29 32.32 26.39 18.23 25.84 15.96 Tax Rate 32.59% 35.54% 8.86% 8.90% 9.02% 9.85% 9.99% 8.46% 5.85% 9.43% 10.37% PAT 244.05 77.39 299.72 398.01 417.19 350.61 291.27 285.38 293.65 248.14 137.97 PAT before Minority Interest 244.05 77.39 299.72 398.01 417.19 350.61 291.27 285.38 293.65 248.14 137.97 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.40% 4.56% 20.16% 29.91% 34.32% 31.62% 28.55% 31.83% 38.61% 34.81% 22.79% PAT Growth 215.35% -74.18% -24.70% -4.60% 18.99% 20.37% 2.06% -2.82% 18.34% 79.85% EPS 17.62 5.59 21.64 28.74 30.12 25.31 21.03 20.61 21.20 17.92 9.96

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 3,129.42 2,893.64 2,009.15 1,685.15 1,347.04 1,211.86 1,074.06 982.16 855.60 749.50 597.02 Net Sales Growth 8.15% 44.02% 19.23% 25.10% 11.15% 12.83% 9.36% 14.79% 14.16% 25.54% Cost Of Goods Sold 795.60 713.99 380.05 352.35 258.51 238.27 171.53 153.70 141.57 133.60 98.48 Gross Profit 2,333.82 2,179.65 1,629.10 1,332.80 1,088.53 973.60 902.53 828.46 714.03 615.90 498.54 GP Margin 74.58% 75.33% 81.08% 79.09% 80.81% 80.34% 84.03% 84.35% 83.45% 82.17% 83.50% Total Expenditure 2,009.32 1,876.44 1,334.32 1,148.40 862.01 781.11 706.17 637.08 533.49 480.36 425.32 Power & Fuel Cost - 15.08 12.04 5.70 4.16 3.95 4.62 3.45 3.17 3.02 3.59 % Of Sales - 0.52% 0.60% 0.34% 0.31% 0.33% 0.43% 0.35% 0.37% 0.40% 0.60% Employee Cost - 505.09 403.82 346.16 250.18 229.30 205.69 190.66 157.32 131.22 124.67 % Of Sales - 17.46% 20.10% 20.54% 18.57% 18.92% 19.15% 19.41% 18.39% 17.51% 20.88% Manufacturing Exp. - 45.10 23.89 15.61 38.81 11.51 13.96 7.81 4.89 5.05 7.87 % Of Sales - 1.56% 1.19% 0.93% 2.88% 0.95% 1.30% 0.80% 0.57% 0.67% 1.32% General & Admin Exp. - 261.45 253.91 206.62 154.21 121.70 135.85 142.38 116.86 121.29 104.36 % Of Sales - 9.04% 12.64% 12.26% 11.45% 10.04% 12.65% 14.50% 13.66% 16.18% 17.48% Selling & Distn. Exp. - 291.05 208.45 185.16 121.39 128.70 140.99 134.82 107.67 84.32 82.75 % Of Sales - 10.06% 10.38% 10.99% 9.01% 10.62% 13.13% 13.73% 12.58% 11.25% 13.86% Miscellaneous Exp. - 44.68 52.16 36.80 34.74 47.69 33.53 4.25 2.00 1.86 82.75 % Of Sales - 1.54% 2.60% 2.18% 2.58% 3.94% 3.12% 0.43% 0.23% 0.25% 0.60% EBITDA 1,120.10 1,017.20 674.83 536.75 485.03 430.75 367.89 345.08 322.11 269.14 171.70 EBITDA Margin 35.79% 35.15% 33.59% 31.85% 36.01% 35.54% 34.25% 35.13% 37.65% 35.91% 28.76% Other Income 7.75 18.36 23.82 11.15 26.09 8.71 16.01 31.69 26.41 25.11 3.37 Interest 192.67 231.29 84.80 26.17 4.22 1.98 2.30 23.06 10.65 1.10 0.28 Depreciation 279.50 315.46 182.51 117.09 64.70 42.98 50.26 36.35 25.64 22.76 20.36 PBT 638.44 488.81 431.34 404.64 442.20 394.50 331.35 317.36 312.23 270.39 154.44 Tax -8.97 114.20 34.22 30.48 36.41 39.36 34.84 26.21 17.25 23.78 19.59 Tax Rate -1.40% 23.36% 7.93% 7.53% 8.23% 9.98% 10.51% 8.26% 5.52% 8.79% 12.68% PAT 647.41 351.84 392.05 382.16 406.11 355.13 296.50 290.80 294.11 246.79 133.57 PAT before Minority Interest 619.42 374.67 397.12 374.16 405.79 355.13 296.51 291.15 294.98 246.61 134.86 Minority Interest -27.99 -22.83 -5.07 8.00 0.32 0.00 -0.01 -0.35 -0.87 0.18 -1.29 PAT Margin 20.69% 12.16% 19.51% 22.68% 30.15% 29.30% 27.61% 29.61% 34.37% 32.93% 22.37% PAT Growth 72.50% -10.26% 2.59% -5.90% 14.36% 19.77% 1.96% -1.13% 19.17% 84.76% EPS 46.74 25.40 28.31 27.59 29.32 25.64 21.41 21.00 21.24 17.82 9.64

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,514.90 2,524.02 2,221.88 1,918.56 1,575.47 1,299.70 1,156.01 868.18 574.60 305.73 Share Capital 13.62 13.60 13.60 13.59 13.58 13.58 13.75 13.75 13.75 0.14 Total Reserves 2,491.12 2,505.36 2,205.48 1,903.07 1,557.91 1,283.27 1,141.06 854.43 560.85 305.59 Non-Current Liabilities 1,430.23 259.97 4.22 -170.49 -161.81 -130.18 -114.05 196.33 -22.95 20.17 Secured Loans 1,632.64 485.94 209.47 0.00 0.00 0.00 0.00 273.69 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 57.98 40.56 31.03 28.84 29.14 24.13 16.47 15.02 19.80 23.10 Current Liabilities 1,010.95 2,322.55 361.73 249.79 212.42 203.06 360.46 277.88 114.26 70.81 Trade Payables 216.08 109.63 83.07 96.77 86.71 89.93 74.93 79.03 25.11 27.89 Other Current Liabilities 376.44 721.86 83.43 26.61 23.37 24.41 195.04 112.61 12.39 8.47 Short Term Borrowings 356.50 1,387.61 55.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 61.93 103.45 140.22 126.41 102.34 88.72 90.50 86.24 76.76 34.44 Total Liabilities 4,956.08 5,106.54 2,587.83 1,997.86 1,626.08 1,372.58 1,402.42 1,342.39 665.91 396.71 Net Block 2,412.18 1,515.56 897.81 642.00 584.32 600.64 483.85 489.75 91.78 64.79 Gross Block 2,875.21 1,811.21 1,094.83 783.40 716.88 695.65 551.80 532.93 113.20 108.20 Accumulated Depreciation 463.03 295.65 197.01 141.40 132.55 95.01 67.96 43.19 21.43 43.41 Non Current Assets 4,311.53 3,169.24 1,957.80 1,334.30 1,134.47 869.37 782.82 958.53 399.30 159.69 Capital Work in Progress 0.27 0.61 0.34 2.98 1.55 4.37 2.73 0.00 0.00 0.00 Non Current Investment 991.27 1,618.95 966.51 678.18 480.97 246.03 274.36 451.84 290.43 62.59 Long Term Loans & Adv. 268.64 27.04 85.95 11.13 25.36 15.44 16.00 10.95 12.19 32.30 Other Non Current Assets 639.17 7.08 7.17 0.00 42.27 2.88 5.88 6.00 4.91 0.00 Current Assets 644.55 1,937.30 630.03 663.56 491.60 503.22 619.60 383.86 266.61 237.02 Current Investments 0.00 0.00 30.00 99.55 50.40 74.27 306.11 93.76 90.18 143.73 Inventories 191.25 91.63 63.70 84.79 64.85 65.46 74.70 57.52 47.20 49.46 Sundry Debtors 236.19 239.97 229.22 137.56 113.76 140.82 75.90 60.50 41.30 25.36 Cash & Bank 92.46 1,296.73 47.65 46.10 32.66 64.95 6.47 8.81 2.06 8.53 Other Current Assets 124.65 25.00 17.47 20.97 229.95 157.71 156.42 163.28 85.87 9.94 Short Term Loans & Adv. 104.35 283.97 241.99 274.60 204.25 109.46 103.14 123.50 82.40 7.81 Net Current Assets -366.40 -385.25 268.30 413.77 279.18 300.16 259.13 105.98 152.35 166.21 Total Assets 4,956.08 5,106.54 2,587.83 1,997.86 1,626.07 1,372.59 1,402.42 1,342.39 665.91 396.71

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,854.36 2,586.18 2,195.99 1,908.31 1,576.42 1,296.33 1,150.52 861.31 567.14 299.62 Share Capital 13.62 13.60 13.60 13.59 13.58 13.58 13.75 13.75 13.75 0.14 Total Reserves 2,830.65 2,567.56 2,179.59 1,892.82 1,558.87 1,279.90 1,135.57 847.56 553.39 299.49 Non-Current Liabilities 2,100.97 979.35 730.02 -78.80 -109.06 -79.63 -65.50 248.09 11.82 19.84 Secured Loans 1,737.51 654.51 644.45 45.00 0.00 0.00 0.29 274.19 0.49 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 78.97 52.72 44.67 32.16 31.47 25.98 19.39 18.71 22.96 23.10 Current Liabilities 1,489.55 2,608.96 521.18 283.34 235.45 220.17 377.25 293.98 129.27 68.95 Trade Payables 332.35 218.93 124.77 117.77 102.62 100.05 84.13 90.77 38.52 24.57 Other Current Liabilities 530.75 900.18 190.12 35.81 29.07 27.44 198.57 115.06 13.52 9.71 Short Term Borrowings 396.59 1,311.31 55.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 229.86 178.54 151.29 129.75 103.76 92.68 94.55 88.15 77.24 34.67 Total Liabilities 6,862.28 6,810.40 3,471.88 2,112.74 1,702.81 1,436.87 1,480.58 1,428.04 732.02 391.61 Net Block 5,306.48 4,319.16 2,568.10 917.94 853.87 874.85 760.54 771.09 231.65 71.37 Gross Block 6,060.83 4,772.87 2,843.17 1,091.96 1,005.79 983.89 838.26 819.52 254.43 123.31 Accumulated Depreciation 754.35 453.71 275.07 174.02 151.92 109.04 77.73 48.42 22.78 51.95 Non Current Assets 5,531.13 4,431.47 2,629.21 1,401.72 1,167.24 901.78 827.09 1,060.81 462.52 169.38 Capital Work in Progress 67.01 19.67 21.72 26.99 1.55 4.37 2.73 0.00 0.07 0.00 Non Current Investment 62.00 15.55 6.69 420.84 243.65 3.20 40.91 271.61 213.05 62.60 Long Term Loans & Adv. 88.29 69.83 25.32 35.94 25.90 16.47 17.03 12.11 12.84 35.41 Other Non Current Assets 7.35 7.26 7.37 0.00 42.27 2.88 5.88 6.00 4.91 0.00 Current Assets 1,331.15 2,378.93 842.67 711.02 535.56 535.10 653.49 367.23 269.50 222.24 Current Investments 5.00 0.00 30.01 99.55 50.40 74.78 314.94 93.76 90.18 127.44 Inventories 334.83 189.03 131.44 117.91 94.47 69.47 82.65 65.45 55.82 47.62 Sundry Debtors 458.64 422.00 292.71 160.97 140.49 156.88 83.98 66.64 48.86 25.37 Cash & Bank 222.83 1,400.64 58.46 52.33 38.28 67.33 7.51 10.64 2.42 9.69 Other Current Assets 309.85 32.14 22.42 24.04 211.94 166.63 164.41 130.74 72.22 12.11 Short Term Loans & Adv. 282.57 335.12 307.65 256.23 175.70 111.48 106.85 86.48 68.48 9.85 Net Current Assets -158.40 -230.03 321.49 427.68 300.12 314.93 276.24 73.25 140.22 153.29 Total Assets 6,862.28 6,810.40 3,471.88 2,112.74 1,702.80 1,436.88 1,480.58 1,428.04 732.02 391.62

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 701.86 336.29 322.33 369.41 395.41 265.25 216.31 236.28 209.72 132.65 PBT 120.05 328.83 436.91 458.54 388.89 323.59 311.78 311.89 273.99 153.93 Adjustment 393.56 144.12 73.70 31.04 36.11 39.36 24.57 7.63 -0.90 17.81 Changes in Working Capital 201.69 -63.18 -110.50 -37.26 38.44 -47.37 -50.18 -15.57 -11.17 -7.53 Cash after chg. in Working capital 715.30 409.77 400.11 452.31 463.44 315.59 286.17 303.95 261.92 164.21 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -13.44 -73.48 -77.79 -82.90 -68.03 -50.34 -69.86 -67.67 -52.21 -31.55 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -358.99 -2,491.89 -513.30 -267.64 -347.86 126.74 2.08 -592.73 -198.67 -45.39 Net Fixed Assets -1,063.66 -716.65 -308.79 -67.95 -18.41 -145.49 -21.60 -419.73 -5.00 -22.68 Net Investments 627.68 -622.44 -218.78 -246.36 -211.07 260.17 -34.87 -164.99 -174.29 -24.03 Others 76.99 -1,152.80 14.27 46.67 -118.38 12.06 58.55 -8.01 -19.38 1.32 Cash from Financing Activity -310.46 2,160.05 193.75 -88.42 -81.13 -333.52 -220.74 363.26 -17.52 -83.70 Net Cash Inflow / Outflow 32.41 4.45 2.78 13.36 -33.58 58.47 -2.34 6.81 -6.48 3.57 Opening Cash & Equivalents 51.93 47.48 44.70 31.35 64.93 6.46 8.81 2.00 8.48 4.91 Closing Cash & Equivalent 84.34 51.93 47.48 44.70 31.35 64.93 6.46 8.81 2.00 8.48

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 1,065.01 486.01 291.74 378.26 375.36 271.17 223.00 234.63 200.21 131.48 PBT 488.87 431.34 404.64 442.20 394.50 331.35 317.36 312.23 270.39 154.44 Adjustment 548.05 254.16 139.84 49.25 44.07 44.24 30.50 14.12 -0.65 19.92 Changes in Working Capital 125.97 -98.74 -175.54 -29.90 5.33 -52.65 -53.24 -22.15 -16.45 -8.21 Cash after chg. in Working capital 1,162.89 586.76 368.95 461.55 443.90 322.94 294.62 304.20 253.29 166.16 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -97.88 -100.75 -77.21 -83.28 -68.53 -51.77 -71.63 -69.56 -53.08 -34.68 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -79.97 -1,854.52 -982.10 -319.61 -323.36 123.23 -5.05 -590.10 -184.46 -43.91 Net Fixed Assets -1,063.66 -716.65 -308.79 -67.95 -18.41 -145.49 -21.60 -419.73 -5.00 -22.68 Net Investments 627.68 -622.44 -218.78 -246.36 -211.07 260.17 -34.87 -164.99 -174.29 -24.03 Others 356.01 -515.43 -454.53 -5.30 -93.88 8.55 51.42 -5.38 -5.17 2.80 Cash from Financing Activity -881.32 1,379.68 688.02 -44.70 -82.39 -334.59 -221.05 363.21 -23.66 -83.70 Net Cash Inflow / Outflow 103.72 11.17 -2.34 13.96 -30.39 59.81 -3.11 7.75 -7.91 3.87 Opening Cash & Equivalents 94.25 56.02 50.87 36.91 67.31 7.50 10.61 2.34 8.87 5.00 Closing Cash & Equivalent 199.74 94.15 56.02 50.87 36.91 67.31 7.50 10.61 2.34 8.87

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 183.90 185.22 163.18 141.00 115.74 95.51 83.97 63.14 41.79 22154.28 ROA 1.54% 7.79% 17.36% 23.02% 23.38% 20.99% 20.79% 29.24% 46.70% 36.93% ROE 3.08% 12.65% 19.25% 23.92% 24.45% 23.76% 28.21% 40.71% 56.37% 48.12% ROCE 6.96% 10.18% 20.54% 26.42% 27.12% 24.74% 25.98% 35.45% 62.40% 53.64% Fixed Asset Turnover 0.74 1.08 1.46 1.67 1.61 1.64 1.65 2.35 6.44 6.43 Receivable days 50.04 54.81 48.81 36.56 40.89 38.77 27.76 24.43 17.07 14.34 Inventory Days 29.73 18.15 19.76 21.77 20.93 25.07 26.92 25.13 24.74 30.25 Payable days 119.06 125.53 138.85 167.72 162.39 56.42 58.45 51.57 30.40 33.54 Cash Conversion Cycle -39.30 -52.57 -70.28 -109.39 -100.57 7.42 -3.77 -2.02 11.41 11.05 Total Debt/Equity 0.88 1.00 0.14 0.00 0.00 0.00 0.15 0.43 0.00 0.00 Interest Cover 1.55 6.73 22.00 151.29 416.49 165.51 14.61 30.77 321.83 556.69

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 208.83 189.79 161.28 140.25 115.81 95.26 83.58 62.64 41.25 21711.81 ROA 5.48% 7.72% 13.40% 21.27% 22.62% 20.33% 20.02% 27.31% 43.89% 36.17% ROE 13.81% 16.64% 18.25% 23.33% 24.78% 24.28% 28.96% 41.30% 56.90% 47.68% ROCE 13.59% 12.37% 17.30% 25.29% 27.60% 25.44% 26.54% 35.76% 62.56% 54.56% Fixed Asset Turnover 0.55 0.56 0.90 1.33 1.25 1.18 1.18 1.59 3.97 5.42 Receivable days 54.07 61.68 46.91 39.44 43.59 40.93 27.99 24.64 18.07 14.56 Inventory Days 32.16 27.66 25.78 27.78 24.03 25.85 27.52 25.87 25.19 31.24 Payable days 140.91 165.04 125.63 155.58 155.23 59.47 59.07 54.07 32.17 33.59 Cash Conversion Cycle -54.68 -75.70 -52.94 -88.36 -87.61 7.30 -3.57 -3.57 11.09 12.21 Total Debt/Equity 0.85 1.06 0.38 0.02 0.00 0.00 0.15 0.44 0.00 0.00 Interest Cover 3.11 6.09 16.46 105.81 200.75 145.25 14.76 30.31 246.14 558.56

Top Investors:

lilac investments limited

hdfc small cap fund

franklin india small cap fund

hetal rasiklal shah

bhikhalal chimanlal shah

Annual Reports:

News Update:

Eris Lifesciences - Quarterly Results
21st May 2026, 00:00 AM

Read More
Eris Lifesciences to launch generic Semaglutide under brand ‘SUNDAE’ in India
21st Mar 2026, 12:03 PM

The company is introducing SUNDAE in multi-dose vial formats at highly accessible pricing starting at Rs 1,290 per month
Read More

Eris Lifesciences Ltd.

Pharmaceuticals & Drugs - Domestic

BSE: 540596 | NSE: ERIS

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Eris Lifesciences Ltd.

Pharmaceuticals & Drugs - Domestic

BSE: 540596 | NSE: ERIS

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: